Manfred Frey

No ORCID on file · 1 paper in corpus

other 2013

p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer

Journal of cancer research and clinical oncology ·doi:10.1007/s00432-013-1432-2

PURPOSE: To evaluate the use of p53-autoantibodies (p53-aab) for monitoring minimal disease after standard therapy of advanced epithelial ovarian cancer (EOC). METHODS: Retrospective analysis of p53-aab in preoperative and long-term follow…